1. Introduction {#s0005}
===============

Milk contains approximately 3.5% protein of which 80% are casein and 20% whey proteins. Caseins have been classified as α-, β- and k-caseins. Whey contains β-lactoglobulin, α-lactalbumin and several minor proteins with different biological activities such as enzymes, mineral-binding properties and immunoglobulins. The multifunctional properties of biologically active milk peptides are increasingly acknowledged. It could show a positive impact on human physiology and metabolism either, directly or through enzymatic hydrolysis *in vivo* or in vitro ([@b0120]). The activity of peptides is based on their inherent amino acid composition and sequence. The size of bioactive peptide sequences known to possess multifunctional properties may vary from two to twenty amino acid residues ([@b0195]).

Biologically active peptides in the protein sequence are defined as fragments that remain inactive in precursor protein sequences, but when released by the action of proteolytic enzymes, they may interact with selected receptors and regulate the body's physiological functions. The effect exerted by such peptides may be positive or negative ([@b0265], [@b0185]). Protease enzymes are naturally occurring in food products, such as milk plasmin, hydrolyze proteins and release bioactive fragments during processing or storage. Many types of bacteria applied in the production of fermented food products and occurring naturally in the gastrointestinal tract are capable of producing biologically active peptides. Cheese contains phospho peptides which are further proteolyzed in the process of cheese ripening, leading to the formation of various ACE inhibitors ([@b0260]).

Biologically active peptides derived from milk are initially found in inactive form within the sequence of the precursor molecules but it can be released in three ways; (i) enzymatic hydrolysis with digestive enzymes like pepsin, trypsin, chymotrypsin etc; (ii) fermentation of milk with proteolytic starter cultures; (iii) proteolysis by enzymes derived from proteolytic microorganisms ([Fig. 1](#f0005){ref-type="fig"}) ([@b0125]). Once these bioactive peptides are liberated, they may serve to influence numerous physiological responses including cardiovascular, digestive, endocrine, immune and neurological activity etc. ([Fig. 2](#f0010){ref-type="fig"}). Because of such physiological versatility, milk-derived bioactive peptides have drawn the attention of many researchers worldwide in order to formulate several potential drugs with nutraceutical supplement properties, health promoting functional foods or other pharmaceutical products ([@b0125], [@b0070]). General characteristics of the primary classes of bioactive milk peptides are discussed in this review.

2. Derivation of bioactive peptides {#s0010}
===================================

Milk peptides are derived from milk proteins by enzymatic breakdown by digestive enzymes or by the proteinase enzymes produced by lactobacilli during the fermentation of milk ([@b0115]). Milk-derived bioactive peptides are usually comprised of 2--20 amino acids and become active after release from the precursor protein where they are encrypted either by digestion or proteolysis both *in vivo* or in vitro ([Fig. 1](#f0005){ref-type="fig"}).

2.1. Gastrointestinal digestion (*in vivo*) {#s0015}
-------------------------------------------

Bioactive peptides may be released *in vivo* during gastrointestinal digestion by the action of digestive enzymes like pepsin, trypsin or chymotrypsin. Dietary proteins undergo denaturation in the presence of hydrochloric acid (HCl) secreted by the parietal cells of the stomach. This acid activates pepsinogen and converts it into its active form, pepsin. Pepsin acts on proteins to metabolise them to amino acids. Gastrointestinal digestion permits the consequent action of the enzymes present in the small intestine such as pepsin, trypsin or chymotrypsin, which are responsible for protein hydrolysis ([@b0125]). Several bioactive peptides (viz., anti-bacterial, immunomodulatory, anti-hypertensive and opioid peptides) are known to be released from casein and/or whey proteins by gastrointestinal digestion ([@b0195], [@b0305], [@b0075], [@b0090], [@b0095]). Some other proteolytic enzymes such as alcalase, thermolysin, may be utilized with pepsin and trypsin in order to simulate gastrointestinal digestion. They have also been employed to release various bioactive peptides, including CCPs ([@b0175]), ACE inhibitory ([@b0290]), anti-bacterial ([@b0210]), anti-oxidative ([@b0275], [@b0255]), immunomodulatory ([@b0080]) and opioid peptides ([@b0240], [@b0245]).

2.2. Microbial fermentation (in vitro) {#s0020}
--------------------------------------

Several lactic acid bacteria (LAB) (e.g. *Lactococcus lactis*, *Lactobacillus helveticus*) have been reported to release bioactive peptides by the process of fermentation. This system consists of a number of distinct intracellular peptidases including endo-peptidases, amino-peptidases, di-peptidases, and tri-peptidases ([@b0040]). Recent studies have reviewed the production of various bioactive peptides including antimicrobial, immunomodulatory, antioxidative and ACE-inhibitory through microbial proteolysis ([@b0095], [@b0125]). The release of bioactive peptides by fermentation of milk using different proteolytic microorganisms or proteolytic enzymes derived from such microorganisms has been summarized in [Table 1](#t0005){ref-type="table"}.

2.3. Enzymatic activity {#s0025}
-----------------------

The most common way to produce bioactive peptides from milk is through enzymatic hydrolysis of the whole protein molecules. Digestive enzymes and combinations of different proteinases including alcalase, chymotrypsin, pepsin and thermolysin as well as enzymes from bacterial and fungal sources have also been utilized to generate bioactive peptides from various proteins.

3. Bioactive peptides and their role in human health {#s0030}
====================================================

3.1. Antimicrobial peptides {#s0035}
---------------------------

Antimicrobial bioactive peptides derived from milk have been reported to inhibit many Gram positive and Gram negative pathogens including *Escherichia coli* MTCC82, *Aeromonas hydrophila* ATCC7966, *Salmonella typhi* MTCC3216, *Bacillus cereus* ATCC10702, *Salmonella typhimurium* SB300, *S. enteritidis* 125109, *Staphylococcus aureus* MTCC 96 ([@b0210]) and control many microbial infections. In a similar way chymosin digested casein releases caseicidin peptide that exhibits antimicrobial activity against *Staphylococcus* spp., *Sarcina* spp., *Bacillus subtilis, Streptococcus pyogenes* ([@b0140])*.* Several such peptides have been detected and some of them are listed in [Table 2](#t0010){ref-type="table"}. A cationic fragment of casein, casocidin-I, is able to inhibit growth of *E. coli* and *S. Carnosus* ([@b0310]) where as two other peptides are isolated from the same casein, namely f183--207 and f164--179 also able to inhibit pathogens ([@b0250]). Lactoferrampin, isolated as a fragment of lactoferrin displays inhibitory activity against *Streptococcus mutans, E. coli, B. subtilis* and *Pseudomonas aeruginosa* ([@b0285]). Researchers have recognized new antibacterial peptides from a chymosin, trypsin digest of αs2-CN bovine, namely, Isracidine, which has a strong protective effect against *S. aureus*, *S. pyogenes* and *Listeria monocytogenes* ([@b0140]). Glyco-macropeptide (GMP) and caseinomacropeptide (CMP) are formed after a specific cleavage of casein by chymosin ([@b0065]). Caseinomacropeptide (CMP) may have an inhibitory activity against *S. mutans* and *E. coli* whereas GMP modulates the gut microflora ([@b0150]). Isfracidin and lactoferricin B are effective against *Candida albicans* ([@b0010], [@b0140]). Lactoferrin and its derivatives show the antibacterial activity in vitro against various pathogens, *e.g. Clostridium perfringens, C. albicans, Haemophilus influenzae, Helicobacter pylori, L. monocytogenes, P. aeruginosa, Salmonella enteritidis, S. aureus, Vibrio cholerae* as well as antiviral activity against hepatitis C,G and B virus HIV-1, poliovirus, rotavirus and herpes simplex virus ([@b0060], [@b0230]).

3.2. Immunomodulatory peptides {#s0040}
------------------------------

Glycopeptides, hormones and peptide fragments of immunoglobulins are usually considered as immunomodulatory peptides that regulate cell-mediated and humoral immune functions. Later on, several other peptides were reported from bovine β-casein, which were responsible for phagocytizes in humans and inhibited *Klebsiella pneumoniae* infection in mice *in vivo* ([@b0205]). More recently many cyto-chemical studies indicate that the immunomodulatory bioactive peptides derived from both casein and whey proteins are related to the stimulation and proliferation of human lymphocytes, macrophage phagocytic activity, antibody synthesis and cytokine regulation ([@b0045], [@b0085]). Cytomodulatory peptides produced from casein may inhibit cancer cell growth by stimulating the activity of immune competent cells ([@b0195]). Glycomacropeptide (GMP) and its derivatives have been revealed to be essential immunomodulatory functions including immune suppressive effects on the production of IgG antibodies ([@b0220], [@b0150]). Lactoferrin is digested to form Lactoferricin B which directly binds to neutrophils and show an opsonin like activity. Other peptides such as f(63--680) and f(191--193) from bovine β-casein may affect phagocytizes in humans in vitro ([@b0205]) where as some other peptides from κ-casein and α-lactalbumin are used in immune therapy of human immune deficiency virus infection ([@b0100]). Caseinomacropeptide (CMP) promotes the growth of bifidobacteria or lactobacilli that inhibit enteric infection ([@b0025]).

3.3. Anti-hypertensive peptides or angiotensin-converting enzyme (ACE) inhibitory peptides {#s0045}
------------------------------------------------------------------------------------------

ACE is a peptidyl di-peptidase enzyme having the capacity to cleave the carboxyl terminal end of the substrate that may regulate an increase in blood pressure by converting angiotensin I to an active peptide hormone angiotensin II. This stimulates the release of aldosterone, as a result of which sodium concentration becomes high and blood pressure goes up. But antihypertensive peptide is able to inhibit ACE to control increase of blood pressure ([@b0130]). ACE inhibitors are di- or tri-peptides containing proline, lysine or arginine at their C-terminal end. Bioactive amino acid sequence displaying antihypertensive activity is mainly isolated from bovine and human caseins. Whey proteins derived by the activity of lactic acid bacteria like *L. helveticus, L. lactis* are resistant to the digestive tract endo-peptidases, therefore, can be easily absorbed to the blood stream ([@b0260]). ACE inhibitory peptides such as β-casein, κ-casein have been isolated from enzymatic digest of sour milk proteins αs1 and β-CN ([@b0015]). In addition to casein derived peptide, ACE inhibitory peptides such as α-lactorphin and β-lactorphin are also generated from whey proteins α-lactalbumin and lactoglobulin, respectively ([@b0155], [@b0160], [@b0165]). The peptides Glu-Met-Pro-Phe-Pro-Lys and Tyr-Pro-Val-Glu-Pro-Phe-Thr-Glu originate from the casein sequences, f(108--113) and f(114--121); the latter showed an in vitro inhibition effect upon ACE ([@b0235]). ACE inhibitor peptides are food derived natural preventives used to control hypertension and could lead to a decrease in the requirement of medicines which exert strong side effects.

3.4. Opioid peptides {#s0050}
--------------------

Opioid peptides are opioid receptor ligands which are encrypted from bovine and human β-casein enzymatically in vitro ([@b0020]) and also found to be present in the endocrine, nervous and immune systems as well as the gastrointestinal tract of mammals. They interact with their endogenous ligands and with exogenous and/or antagonist opioids and may influence the central or peripheral nervous systems which are involved in hypotension, lack of appetite, fluctuating body temperature and alteration of sexual behaviors ([@b0215], [@b0055]). Endogenous opioid agonist peptides may regulate the growth and function of cells involved in the central nervous system whereas β-casomorphins are transported across mucosal membranes of neonates that regulate physiological responses resulting in calmness and sleep in infants ([@b0030], [@b0270]). On other hand, β-casomorphin interacts with opiate receptors in the serosal side of the intestinal epithelium and plays a crucial role in certain activities like regulation of electrolyte transport, insulin secretion and food absorption ([@b0280]). Opioid antagonists are able to suppress the agonist activity of enkephalin. Two most useful agonistic opioid peptides known as Serorphine and Casoxin C have been isolated from f(399--404) fragments of bovine serum albumin and bovine κ-CN receptor respectively ([@b0190]). There are several accumulating evidences suggesting that two bovine casoxins (casoxins A and B) are opioid receptor ligands that have relatively low antagonistic potency ([@b0180]). Casoxins A and B correspond to amino-acid sequences within bovine k-casein; casoxin A is accounted for by f(35--41) of k-casein (i.e. Tyr-Pro-Ser-Tyr-Gly-Leu-Asn) corresponds to, whereas casoxin B corresponds to f58--61 of k-casein (i.e. Tyr-Pro-Tyr-Tyr). Lastly, casoxin C is a potent opioid antagonist peptide of k-casein f(25--34) (i.e. Tyr-Ile-Pro-Ile-Gln-Tyr-Val-Leu-Ser-Arg), possesses the highest biological potency ([@b0300]). Presently, data suggest that casomorphins, as opioid ligands, exert anti-secretory action ([@b0050]), stimulate analgesic behavior ([@b0170]) and endocrine responses such as secretion of insulin and somatostatin ([@b0200]).

3.5. Antioxidant peptides {#s0055}
-------------------------

Several milk peptides also play a regulatory role in oxidative metabolism which is essential for the survival of cells and causes oxidative changes by producing free radicals. But when an excess of free radicals is released, they oxidize cellular protein, membrane lipid, DNA, and enzymes that cause shutting down of cellular respiration and mediate injuries including atherosclerosis, diabetes, rheumatoid arthritis and oxidative DNA-damage leading to cancer ([@b0005], [@b0105], [@b0110]). Moreover, milk-derived anti-oxidative peptides are comprised of five to eleven hydrophobic amino acids including proline, histidine, tyrosine or tryptophan in sequence which are widely distributed among caseins, soybean and gelatine in hydrolysis by proteolytic enzymes ([@b0125]) as shown in [Table 3](#t0015){ref-type="table"}. They may function by scavenging or preventing the formation of radicals ([@b0035], [@b0295]), particularly, free radicals released from casein peptides may influence scavenging activity ([@b0275], [@b0255]) and also inhibit enzymatic and non-enzymatic lipid peroxidation. Extensive researches on anti-oxidative peptides have revealed that, the artificial antioxidants provide strong antioxidant activity against several oxidation systems. Because of their strong side effects on human physiology and metabolism, these are restricted in some countries and natural antioxidants have therefore been developed from plants ([@b0225]). Naturally occurring vitamins (E and C), beta-carotene, and enzymatic systems, mainly superoxide dismutase, catalase and glutathione peroxidase have anti-oxidative activities ([@b0145]).

4. Conclusion {#s0060}
=============

Bioactive peptides have attracted the interest of researchers as a health promoting functional food. Yet there is limited work done in this area due to lack of advanced technologies, enriched products and molecular approaches. There is an urgent need to focus on developing novel facilities including advanced proteomics approaches, recombinant enzyme technologies and microbial fermentation, to study the various impacts of bioactive peptides on expression of genes and also to optimize the nutritional and health effects of these compounds. Consequently allergenicity, toxicity and stability of its biological functions during gastrointestinal digestion should be tested in formulation of products incorporated with bioactive peptides. Moreover, preliminary beneficial effects of milk derived bioactive peptides on target diseases should be considered carefully before it can be formulated as chemotherapeutical agents or may try to use them directly in their viable condition. Hence separation and identification of these peptides and their pharmaco-dynamic parameters are necessary to transfer their potent functional properties into food and clinical applications. Scientific researches and industrial development in the direction of searching novel bioactive peptides promise to formulate several drugs and health beneficial functional foods.
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###### 

Bioactive peptides released from milk proteins by various microorganisms.

  Microorganism                                               Precursor protein   Peptide sequence                                                        Bioactivity
  ----------------------------------------------------------- ------------------- ----------------------------------------------------------------------- --------------------------------------------
  *L. rhamnosus* + digestion with pepsin                      β-cn                Asp-Lys-Ile-His-Pro-Phe, Tyr-Gln-Glu-Pro- Val-Leu                       ACE inhibitory
  *Lactobacillus helveticus*                                  β-cn, κ-cn          Val-Pro-Pro, Ile-Pro-Pro                                                ACE inhibitory, antihypertensive
  Lactobacillus GG enzymes + pepsin and trypsin               β-cn, as1-cn        Tyr-Pro-Phe-Pro, Ala-Val-Pro-Tyr-Pro-Gln Arg, Thr-Thr-Met-Pro-Leu-Trp   Opioid, ACE-inhibitory, immune-stimulatory
  *Lactobacillus delbrueckii* subsp., *bulgaricus* IFO13953   κ-cn                Ala-Arg-His-Pro-His-Pro-His-Leu-Ser-Phe-met                             Antioxidative
  *Kluyveromyces marxianus* var.                              β-lg                Tyr-Leu-Leu-Phe                                                         ACE-inhibitory
  *Lactobacillus helveticus* CP90 proteinase                  β-cn                Lys-Val-Leu-Pro-Val-Pro-(Glu)                                           ACE-inhibitory

###### 

Anti-microbial peptides derived from milk and their target microorganisms.

  Milk peptides                                Protease                   Pathogens
  -------------------------------------------- -------------------------- ------------------------------------------------------------------------------------------------------------------------------
  Isracidin *α*s1-CN (f1--23)                  Chymosin, chymotrypsin     *Staphylococcus aureus*
  Casecidin *αs1* and *κ-CN*                   Chymosin, chymotrypsin     *Staphylococcus, Bacillus subtilis, Diplococcus pneumonia, Streptococcus pyogenes*
  Lactoferricin B and Lactoferrin (f 17--41)   Pepsin                     *Bacillus, E. coli, Candida albicans, Listeria, Streptococci, Klebsiella, Staphylococci, Proteus, Pseudomonas*, *Salmonella*
  β-Casein derived peptides                    Trypsin and chymotrypsin   *Enterococcus faecium*, *Bacillus megaterium*

###### 

Anti-oxidative peptides derived from milk proteins.

  Protein source           Enzyme     Peptide sequence                                                                                              Antioxidative activity                                         References
  ------------------------ ---------- ------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- ------------
  Casein                   Trypsin    Val-Lys-Glu-Ala-Met-Ala-Pro-Lys                                                                               Inhibition of enzymatic and non-enzymatic lipid peroxidation   [@b0275]
  Casein                   Pepsin     Tyr-Phe-Tyr-Pro-Glu-Leu                                                                                       Radical scavenging activity                                    [@b0255]
  β-Lactoglobulin (β-lg)   Corolase   Trp-Tyr-Ser-Leu-Ala-Met-Ala-Ala-Ser-Asp-Ile Trp-Tyr-Ser-Leu-Ala-Met-Ala-Ala-Ser-Asp-Ile Tyr-Val-Glu-Glu-Leu   Radical scavenging activity                                    
